Cabotegravir Sodium Side Effects and Medication Safety Complete Guide

　　1.Basic Drug Information

　　Cabotegravir Sodium(Cabotegravir),brand name Vocabria,is an HIV integrase strand transfer inhibitor(INSTI)mainly used for HIV-1 infection treatment and pre-exposure prophylaxis(PrEP).The drug was approved by China's National Medical Products Administration(NMPA)in July 2023.It can be used orally alone or combined with long-acting injectable for long-term treatment of HIV感染者.Suitable for adults and adolescents aged 12 years and older weighing at least 35 kg with HIV-1 infection or at risk of infection.

　　2.Mechanism of Action

　　Cabotegravir Sodium inhibits HIV integrase,preventing viral DNA from integrating into the host cell genome,thereby inhibiting viral replication.The drug has high activity against HIV-1 virus but limited effect on HIV-2 virus.As an integrase inhibitor,Cabotegravir Sodium has efficient antiviral activity and good tolerability,significantly reducing the number of medication days for感染者.

　　3.Common Side Effects Details

　　Common side effects of Cabotegravir Sodium include headache,nausea,diarrhea,fatigue,dizziness,insomnia and other gastrointestinal and neurological symptoms.According to clinical research data,headache incidence rate is approximately 17%-23%,diarrhea incidence rate is approximately 14%.These adverse reactions are usually mild to moderate,mostly appearing during early treatment,and may resolve spontaneously over time.If symptoms persist or worsen,inform your doctor promptly.

　　4.Skin and Allergic Reactions

　　Some patients may experience skin reactions such as rash and itching.Severe skin reactions like Stevens-Johnson syndrome are rare but require high vigilance.If severe rash,oral ulcers,eye redness,fever or blisters occur,stop medication immediately and seek medical attention.Patients with previous drug allergy history should inform doctors in advance.Hypersensitivity reactions require special vigilance during oral lead-in period.

　　5.Liver Safety

　　Cabotegravir Sodium may cause liver function abnormalities,manifested as elevated transaminases.Clinical research shows transaminase elevation incidence rate is approximately 19%.Most cases are mild and asymptomatic,but少数patients may develop severe liver injury.Liver function needs regular monitoring during treatment.Patients with previous liver disease or concurrently using other hepatotoxic drugs need special caution.Seek medical attention promptly if jaundice or significant liver function abnormalities occur.

　　6.Psychiatric and Neurological Reactions

　　Some patients may experience psychiatric symptoms such as depression,anxiety,sleep disorders,and abnormal dreams.Neurological symptoms including headache,dizziness,and drowsiness have also been reported.These reactions are usually tolerable.If daily life is seriously affected,discuss adjustment plans with your doctor.Patients with previous psychiatric disease history have increased depression risk and require close monitoring of mood changes.

　　7.Drug Interactions

　　Cabotegravir Sodium may interact with certain medications.Concurrent use with CYP3A4 inducers such as Rifampin and Rifabutin may reduce Cabotegravir Sodium blood concentration,affecting efficacy.Concurrent use with antacids or supplements containing magnesium,aluminum,calcium,iron and other cations may reduce absorption,requiring at least 2 hours interval between doses.Interaction risks need evaluation when using other antiretroviral drugs.

　　8.Special Population Considerations

　　Safety data for Cabotegravir Sodium use in pregnant women is limited;use only after thorough risk assessment.Nursing women using this medication should stop breastfeeding.Renal impairment patients usually do not need dose adjustment,but data for severe renal impairment patients is limited,requiring careful evaluation.Not recommended for children under 12 years old or weighing less than 35 kg.

　　9.Price and Access Information

　　Cabotegravir Sodium is available in mainland China,manufactured by ViiV Healthcare.In overseas markets,drug prices vary by region.Patients can obtain through regular medical institutions.Consult professional doctors for local availability and specific cost information.

　　10.Medication Safety Precautions

　　When using Cabotegravir Sodium:take medication on time,do not adjust dose independently;if a dose is missed,take it as soon as possible but do not take double dose;regularly monitor HIV viral load and CD4 cell count;regularly test liver function during treatment;seek medical attention promptly for any discomfort symptoms.The drug is not 100%effective;when used for pre-exposure prophylaxis,combine with comprehensive prevention strategies including safe sexual behaviors.